Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Completed · Phase 2

Conditions studied: Carcinoma, Non Small Cell Lung

In brief

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer

Key facts

Study ID

NCT00191230

Run by

Eli Lilly and Company

People needed

70

Starts

2001-09-01

Expected to finish

2006-07-01

Last updated by the study team

2007-01-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically of cytologically confirmed non small cell lung cancer
• No prior chemotherapy or radiation
• No prior malignancy

You may not qualify if…

• Pregnant or breastfeeding
• Serious concomitant systemic disorder

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.